YU, X.; LIU, J.; QIU, H.; HAO, H.; ZHU, J.; PENG, S. Combined inhibition of ACK1 and AKT shows potential toward targeted therapy against KRAS-mutant non-small-cell lung cancer. Bosnian Journal of Basic Medical Sciences, v. 21, n. 2, p. 198-207, 1 Apr. 2021.